Prevalence of Abelson murine leukemia viral oncogene homolog-breakpoint cluster region fusions and correlation with peripheral blood parameters in chronic myelogenous leukemia patients in Lorestan Province, Iran

Ali Asghar Kiani, Lorestan University of Medical science and Farhad Shahsavar, Lorestan University of Medical science and Mojtaba Gorj, Lorestan University of Medical science and Kolsoum Ahmadi, Lorestan University of Medical science and Vahideh Heydari Nazarabad, Lorestan University of Medical science and Banafsheh Bahmani, Lorestan University of Medical science (2016) Prevalence of Abelson murine leukemia viral oncogene homolog-breakpoint cluster region fusions and correlation with peripheral blood parameters in chronic myelogenous leukemia patients in Lorestan Province, Iran. Int J Appl Basic Med Res, 6 (6). pp. 271-275.

Preview

Text 44.pdf Download (459kB) | Preview

Abstract

Context: Chronic myelogenous leukemia (CML) is a chronic malignancy of myeloid linage associated with a significant increase in granulocytes in bone marrow and peripheral blood. CML diagnosis is based on detection of Philadelphia chromosome and “Abelson murine leukemia viral oncogene homolog” (ABL)‑“breakpoint cluster region protein” fusions (ABL‑BCR fusions). Aims: In this study, patients with CML morphology were studied according to ABL‑BCR fusions and the relationship between the fusions and peripheral blood cell changes was examined. Materials and Methods: All patients suspected to chronic myeloproliferative disorders in Lorestan Province visiting subspecialist hematology clinics who were confirmed by oncologist were studied over a period of 5 years. After completing basic data questionnaire, blood samples were obtained with informed consent from the patients. Blood cell count and morphology were investigated and RNA was extracted from blood samples. cDNA was synthesized from RNA and ABL‑BCR fusions including b3a2 and b2a2 (protein 210 kd or p210), e1a2 (protein 190 kdor p190), and e19a2 (protein 230 kdor p230) were studied by multiplex reverse transcription polymerase chain reaction method. Coexistence of e1a2 and b2a2 (p210/p190) fusions was also studied. The prevalence of mutations and their correlation with the blood parameters were statistically analyzed. Results: Of 58 patients positive for ABL‑BCR fusion, 18 (30.5%) had b2a2 fusion, 37 (62.71%) had b3a2 fusion and three (3.08%) had e1a2 fusion. Coexistence of e1a2 and b2a2 (p210/p190) was not observed. There was no significant correlation between ABL‑BCR fusions and white blood cell count, platelet count, and hemoglobin concentration. Conclusions:The ABL‑BCR fusions in Lorestan Province were similar to other studies in Iran, and b3a2 fusion had the highest prevalence in the studied patients studied. Key words: Breakpoint cluster region‑Abelson murine leukemia viral oncogene homolog positive, chronic, leukemia, myelogenous, peripheral blood

Actions (login required)

View Item